Menu
Not yet recruiting NCT07179666

Comparing Neural Mobilization and Traditional Physiotherapy in Plantar Fasciitis Patients

No phase Interventional Plantar Fasciitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Neural moblization group, Conventional therapy group.
Who it may be relevant to
Registry conditions: Plantar Fasciitis. Basic parameters: 19 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effectiveness of Neural Mobilization in Patients With Planter Fasciitis: A Pilot Study

Overview

To evaluate the short-term effectiveness of neural mobilization targeting the posterior tibial nerve compared to traditional physiotherapy in cases diagnosed with plantar fasciitis, a pilot study will be conducted on 12 patients who will have been diagnosed with plantar fasciitis. Participants will be randomly divided into either the neural mobilization group or the conventional physiotherapy group, and all will receive three weeks of structured treatment. Results will be evaluated using techniques that will measure plantar pressure with Algometry, Foot Function Index (FFI) scores, and the Foot Health Status Questionnaire (FHSQ). Differences before and after treatment will be tested within the group using paired t-tests, and others will be examined between the groups with independent t-tests.

Interventions

  • Other Neural moblization group
    The intervention will involve neural mobilization of the tibial nerve, beginning with distal sliding through ankle dorsiflexion and foot eversion, followed by dorsiflexion of the toes. The movement will then be reversed into plantarflexion to allow proximal nerve excursion. In addition, a tensioner technique will be applied, in which participants will perform 45° hip flexion combined with ankle dorsiflexion and eversion, followed by knee extension, to place a controlled tensile load along the ti
  • Other Conventional therapy group
    The intervention will include manual therapy techniques such as myofascial release and soft tissue mobilization to reduce fascial tension and improve local circulation. Stretching exercises will be prescribed to target the plantar fascia, Achilles tendon, and gastrocnemius-soleus complex in order to enhance flexibility and reduce mechanical strain. In addition, ultrasound therapy will be utilized for its thermal and non-thermal effects to promote tissue healing and reduce inflammation.

Primary outcome measures

  • Foot Function Index [Time frame: 3 weeks]
  • Foot Health Status Questionnaire [Time frame: 3 weeks]

Eligibility criteria

Inclusion criteria

  • Participants will be selected within the age range of 19 to 40 years
  • Meet the diagnostic criteria for plantar fasciitis, including symptoms of first-step pain in the morning and heel pain after long periods of standing, confirmed through clinical examination.

Exclusion criteria

  • Individuals will be omitted from the study if they have undergone foot or ankle or foot surgery during the prior 12 months
  • The presence of severe osteoarthritis, diabetic foot ulcers, or neuropathy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07179666 · IRB-COHS-STD-137-Mar-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗